Echinacea purpurea

Echinacea purpurea

Best for

Catch fewer colds and infections

Proven strong benefit for 2–23 weeks · 3 studies , n=882

9 papers · 4 claims · 24 outcomes scored · 4 positive

Outcomes

What echinacea purpurea actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Catch fewer colds and infections Proven strong benefit
large
3 RCTs n=882 2.5–4000 mg 2–23 wk #4/17
Ease cold and flu severity Faint early signal
small
4 RCTs n=206 2.5–4000 mL 1–16 wk
Ease bronchitis symptoms Faint early signal
small
2 RCTs n=86 2.5–15 mL 1–2 wk #1/2
Recover from colds faster Not enough research
trivial
2 RCTs n=58 1200–16800 mg 1–16 wk #4/10

Risk profile

Adverse events and known drug interactions

Safety events

oral aphthous ulcer severe
serious adverse events (unrelated fractures) severe
anaphylaxis severe
mild adverse effects mild
sleeplessness
no significant side effects reported
Vomiting and non-urticarial rash
Any adverse event (AE)

Drug interactions

Ritonavir major decreases concentration
Indinavir major decreases concentration
Nevirapine major decreases concentration
Efavirenz major decreases concentration
Cyclosporine major decreases concentration
Theophylline major decreases concentration
Cyclosporine major decreases effect
Midazolam moderate decreases concentration
Cyclosporine moderate unknown
Caffeine moderate decreases concentration

Co-studied with

Supplements that share evidence with echinacea purpurea

Want personalized recommendations?

Show me what works for me